SanegeneBio Employee Directory

SanegeneBio corporate office is located in 300 Tradecenter Ste 5500, Woburn, Massachusetts, 01801, United States and has 51-200 employees.

Employees by Department

Departments

Number of employees

Engineering & Technical

8

Operations

5

Finance

2

Sales

2

C-Suite

1

Marketing

1

Legal

1

Key Employees of SanegeneBio

  • MA
    United States flag for contact location.
    Marc Abrams

    Head Chief Technology Officer, Operations (US)

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

SanegeneBio Global Presence

globalPresence illustration
North America11-50
Asia1-10

Index of contact profiles from SanegeneBio

Hundreds of professionals searching for SanegeneBio have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at SanegeneBio

Explore people who held key positions, contributed to SanegeneBio's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in Massachusetts, United States

Frequently Asked Questions Regarding SanegeneBio Employees

How many employees does SanegeneBio have?
SanegeneBio has 51-200 employees
Who are SanegeneBio key employees?
Some of SanegeneBio key employees are Marc Abrams
Where is SanegeneBio located?
SanegeneBio’s headquarters are located at 300 Tradecenter Ste 5500, Woburn, Massachusetts, 01801, United States
How do I contact SanegeneBio?
SanegeneBio Contact Info: Website: www.sanegenebio.com
What does SanegeneBio do?

SanegeneBio is a global, venture-backed, fully-integrated biotechnology company focused on developing RNAi-based therapeutics. Founded in 2021 and led by a team of RNAi veterans, the company has R&D operations in Boston, Shanghai and Suzhou. Their clear vision is that RNAi technology will power blockbuster medicines in diverse therapeutic areas, im... proving the quality and longevity of life for patients worldwide. This vision is being realized by advancing a fast-growing pipeline, which includes experimental medicines for autoimmune nephropathies, obesity, and cardiometabolic indications. SanegeneBio has initiated clinical trials for four experimental medicines to-date, and is committed to developing potential best-in-class and first-in-class therapeutics which leverage the company's industry-leading and differentiated LEAD tissue-selective RNAi delivery technology.Read More

Is SanegeneBio a public company?
SanegeneBio is private company therefore does not currently have an official ticker symbol
See more information about SanegeneBio Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.